ValuEngine upgraded shares of Sunshine Heart Inc (NASDAQ:CHFS) from a strong sell rating to a sell rating in a report released on Tuesday.
Sunshine Heart (NASDAQ:CHFS) opened at $6.53 on Tuesday.
In related news, major shareholder Ki Yong Choi purchased 61,645 shares of the company’s stock in a transaction on Thursday, October 12th. The stock was bought at an average price of $0.52 per share, with a total value of $32,055.40. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 2.00% of the company’s stock.
About Sunshine Heart
CHF Solutions, Inc, an early-stage medical device company, develops cardiac and coronary disease products primarily in the United States. It focused on commercializing the Aquadex FlexFlow system, which is indicated for temporary ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy, and extended ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization.
To view ValuEngine’s full report, visit ValuEngine’s official website.
What are top analysts saying about Sunshine Heart Inc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Sunshine Heart Inc and related companies.